<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: DYRK1A plays different functions during development, with an important role in controlling brain growth through neuronal proliferation and neurogenesis </plain></SENT>
<SENT sid="1" pm="."><plain>It is expressed in a gene dosage dependent manner since dyrk1a haploinsufficiency induces a <z:mp ids='MP_0000774'>reduced brain size</z:mp> in mice, and DYRK1A overexpression is the candidate gene for <z:hpo ids='HP_0001249'>intellectual disability</z:hpo> (ID) and <z:hpo ids='HP_0000252'>microcephaly</z:hpo> in <z:e sem="disease" ids="C0013080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Down syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We have identified a 69 kb deletion including the 5' region of the DYRK1A gene in a patient with <z:hpo ids='HP_0001510'>growth retardation</z:hpo>, primary <z:hpo ids='HP_0000252'>microcephaly</z:hpo>, <z:hpo ids='HP_0001999'>facial dysmorphism</z:hpo>, <z:hpo ids='HP_0001250'>seizures</z:hpo>, <z:hpo ids='HP_0002066'>ataxic gait</z:hpo>, <z:hpo ids='HP_0001344'>absent speech</z:hpo> and ID </plain></SENT>
<SENT sid="3" pm="."><plain>Because four patients previously reported with intragenic DYRK1A rearrangements or 21q22 microdeletions including only DYRK1A presented with overlapping phenotypes, we hypothesised that DYRK1A mutations could be responsible for syndromic ID with severe <z:hpo ids='HP_0000252'>microcephaly</z:hpo> and <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: The DYRK1A gene was studied by direct sequencing and quantitative PCR in a cohort of 105 patients with ID and at least two symptoms from the <z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome</z:e> spectrum (<z:hpo ids='HP_0000252'>microcephaly</z:hpo> &lt; -2.5 SD, <z:hpo ids='HP_0002066'>ataxic gait</z:hpo>, <z:hpo ids='HP_0001250'>seizures</z:hpo> and <z:hpo ids='HP_0000750'>speech delay</z:hpo>) </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: We identified a de novo frameshift mutation (c.290_291delCT; p.Ser97Cysfs*98) in a patient with <z:hpo ids='HP_0001510'>growth retardation</z:hpo>, primary severe <z:hpo ids='HP_0000252'>microcephaly</z:hpo>, <z:e sem="disease" ids="C0023012" disease_type="Mental or Behavioral Dysfunction" abbrv="">delayed language</z:e>, ID, and <z:hpo ids='HP_0001250'>seizures</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: The identification of a truncating mutation in a patient with ID, severe <z:hpo ids='HP_0000252'>microcephaly</z:hpo>, <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e>, and <z:hpo ids='HP_0001510'>growth retardation</z:hpo>, combined with its dual function in regulating the neural proliferation/neuronal differentiation, adds DYRK1A to the list of genes responsible for such a phenotype </plain></SENT>
<SENT sid="7" pm="."><plain>ID, <z:hpo ids='HP_0000252'>microcephaly</z:hpo>, <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e>, and <z:hpo ids='HP_0000750'>language delay</z:hpo> are the more specific features associated with DYRK1A abnormalities </plain></SENT>
<SENT sid="8" pm="."><plain>DYRK1A studies should be discussed in patients presenting such a phenotype </plain></SENT>
</text></document>